Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis

INTRODUCTION: Contraceptive implants containing etonogestrel and levonorgestrel have emerged as popular contraceptive options among women in areas of high HIV burden in sub‐Saharan Africa. However, recent pharmacokinetic data have shown drug–drug interactions between implants and efavirenz‐containin...

Descripción completa

Detalles Bibliográficos
Autores principales: Stalter, Randy M., Amorim, Gustavo, Mocello, A. Rain, Jakait, Beatrice, Shepherd, Bryan E., Musick, Beverly, Bernard, Caitlin, Bukusi, Elizabeth A., Wools‐Kaloustian, Kara, Cohen, Craig R., Yiannoutsos, Constantin T., Patel, Rena C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454412/
https://www.ncbi.nlm.nih.gov/pubmed/36073977
http://dx.doi.org/10.1002/jia2.26001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454412/
https://www.ncbi.nlm.nih.gov/pubmed/36073977
http://dx.doi.org/10.1002/jia2.26001

Ejemplares similares